DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 142 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q4 2017. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $232,000 | -18.0% | 31,704 | +2.5% | 0.13% | -25.4% |
| Q4 2018 | $283,000 | +14.1% | 30,944 | +54.5% | 0.17% | +218.9% |
| Q3 2018 | $248,000 | -69.4% | 20,023 | -45.7% | 0.05% | -55.1% |
| Q3 2017 | $811,000 | +6.7% | 36,870 | -53.2% | 0.12% | +14.6% |
| Q2 2017 | $760,000 | +8.6% | 78,774 | -33.0% | 0.10% | +10.8% |
| Q1 2017 | $700,000 | +137.3% | 117,568 | +57.5% | 0.09% | +132.5% |
| Q4 2016 | $295,000 | +23.9% | 74,639 | +189.6% | 0.04% | +11.1% |
| Q3 2016 | $238,000 | -24.9% | 25,776 | +18.5% | 0.04% | -34.5% |
| Q2 2016 | $317,000 | -14.6% | 21,753 | +12.7% | 0.06% | -14.1% |
| Q1 2016 | $371,000 | +28.4% | 19,295 | +61.2% | 0.06% | +3.2% |
| Q4 2015 | $289,000 | +5.5% | 11,966 | +7.1% | 0.06% | -36.7% |
| Q3 2015 | $274,000 | – | 11,168 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 8,415,000 | $105,945,000 | 12.42% |
| Chicago Capital, LLC | 5,842,906 | $73,562,000 | 4.06% |
| PFM Health Sciences, LP | 3,805,370 | $47,910,000 | 1.83% |
| Rhenman & Partners Asset Management AB | 800,000 | $10,072,000 | 1.14% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 2,320,000 | $29,209,000 | 0.71% |
| Rock Springs Capital Management LP | 1,681,458 | $21,170,000 | 0.62% |
| FEDERATED HERMES, INC. | 16,022,731 | $201,726,000 | 0.55% |
| FIRETHORN WEALTH PARTNERS, LLC | 47,376 | $665,000 | 0.54% |
| Jackson Creek Investment Advisors LLC | 82,435 | $1,185,000 | 0.48% |
| OBERWEIS ASSET MANAGEMENT INC/ | 137,200 | $1,727,000 | 0.44% |